Join BJS Academy
BJS Academy>Randomized clinical ...>Effect of total brea...
Normal View Dyslexic View

Effect of total breast reconstruction with autologous fat transfer using an expansion device vs implants on quality of life among patients with breast cancer. A randomized clinical trial.

19 July 2023
Randomized clinical trials Breast
Piatkowski AA, Wederfoort JLM, Hommes JE, Schop SSJ, Krastev TK, van Kuijk SMJ et al, for the Breast Reconstruction With External Preexpansion & Autologous Fat Transfer vs Standard Therapy (BREAST) Trial Investigators.

JAMA Surg 2023; 158: 456-464.

There was no evidence that fat transfer was unsafe in this study that included 193 women. Quality of life was improved in all five domains in women who had the fat transfer procedure in the 132 women who completed the study (all domains P<0.05). There were no differences in complications or oncological outcomes.

Comment: Less invasive than breast reconstruction.

BJS Foundation Limited
BJS Academy
0000-0000
BJS Foundation Limited
London, UK
rct101
Randomized clinical trials
Randomized clinical trials
Breast
Effect of total breast reconstruction with autologous fat transfer using an expansion device vs implants on quality of life among patients with breast cancer. A randomized clinical trial.
Piatkowski AA, Wederfoort JLM, Hommes JE, Schop SSJ, Krastev TK, van Kuijk SMJ et al, for the Breast Reconstruction With External Preexpansion & Autologous Fat Transfer vs Standard Therapy (BREAST) Trial Investigators.
19072023
JAMA Surg 2023; 158: 456-464.
There was no evidence that fat transfer was unsafe in this study that included 193 women. Quality of life was improved in all five domains in women who had the fat transfer procedure in the 132 women who completed the study (all domains P<0.05). There were no differences in complications or oncological outcomes.
Comment: Less invasive than breast reconstruction.
Published on: 19 July 2023
Article ID: rct101

Related articles

Aspirin vs placebo as adjuvant therapy for breast cancer. The Alliance A011502 randomized trial.

Chen WY, Ballman KV, Partridge AH, Hahn OM, Briccetti FM et al.

16 August 2024

21-Gene assay to inform chemotherapy benefit in node-positive breast cancer.

Kalinsky K, Barlow WE, Gralow JR, Meric-Bernstam F, Albain KS, Hayes DF et al.
N Engl J Med 2021; 385: 2336-2347

1 January 2022

Event-free survival with pembrolizumab in early triple-negative breast cancer.

Schmid P, Cortes J, Dent R, Pusztai L, McArthur H, Kummel S et al, for the KEYNOTE-522 Investigators.
N Engl J Med 2022; 386: 556-567.

1 March 2022
Home
  • Normal view
  • Dyslexic view
Info
Copied!